Canada markets close in 4 hours 51 minutes

Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.1746+0.2446 (+6.22%)
As of 11:09AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
50,583
50,583
47,680
50,832
45,849
Cost of Revenue
20,831
20,831
19,386
14,989
12,964
Gross Profit
29,752
29,752
28,294
35,843
32,885
Operating Expenses
Research Development
13,104
13,104
17,481
17,047
19,886
Selling General and Administrative
31,750
31,750
52,879
53,475
55,892
Total Operating Expenses
44,854
44,854
70,360
70,522
75,778
Operating Income or Loss
-15,102
-15,102
-42,066
-34,679
-42,893
Interest Expense
7,462
7,462
12,443
22,461
13,022
Total Other Income/Expenses Net
-1,382
-1,382
-
-13,822
-
Income Before Tax
-7,625
-7,625
-54,410
-70,539
-55,783
Income Tax Expense
245
245
0
0
0
Income from Continuing Operations
-7,870
-7,870
-54,410
-70,539
-55,783
Net Income
-7,870
-7,870
-54,410
-70,539
-55,783
Net Income available to common shareholders
-7,870
-7,870
-54,410
-70,539
-55,783
Basic EPS
-0.22
-
-1.12
-1.85
-1.66
Diluted EPS
-0.22
-
-1.12
-1.85
-1.66
Basic Average Shares
58,053
-
48,734
38,078
33,651
Diluted Average Shares
59,749
-
48,734
38,078
33,651